QQ客服 官方微博 反馈留言

浏览/检索结果: 共29条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Noninvasive imaging in cancer immunotherapy: The way to precision medicine 期刊论文 2019, 卷号: 466, 页码: 13-22 作者:  Du Yang;  Qi Yafei;  Jin Zhengyu;  Tian Jie 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03 Cancer  Immune checkpoint inhibitor  Immunotherapy  Molecular imaging  Precision medicine   Research progress on the immune checkpoint inhibitors induced cardiotoxicity 期刊论文 2019, 卷号: 47, 期号: 9, 页码: 748-751 作者:  Lyu S S;  Yang Y M 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Immune-Related Adverse Events of Immune Checkpoint Inhibitors-From a Clinical to Pathophysiological View 期刊论文 2019 作者:  Yang Xu;  Lin Jianzhen;  Zhao Haitao 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03 Changes in Expression of Multiple Checkpoint Molecules and Infiltration of Tumor Immune Cells after Neoadjuvant Chemotherapy in Gastric Cancer 期刊论文 2019, 卷号: 10, 期号: 12, 页码: 2754-2763 作者:  Yu, Yue;  Ma, Xiaopeng;  Zhang, Yanjuan;  Zhang, Yun;  Ying, Jianming 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 tumor-infiltrating immune cells  checkpoint molecules  neoadjuvant chemotherapy  locally advanced gastric cancer  prognosis   Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma 期刊论文 2019, 卷号: 8, 期号: 7 作者:  Liu, Shasha;  Zhang, Chaoqi;  Maimela, Nomathamsanqa Resegofetse;  Yang, Li;  Zhang, Zhen 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 CD163  glioma  immunotherapy  prognosis  immune checkpoint   Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data 期刊论文 2019, 卷号: 76, 页码: 105866 作者:  Fan Qianqian;  Hu Yang;  Yang Changqing;  Zhao Bin 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Adverse drug events  Data mining  Immune checkpoint inhibitors  Myocarditis  Spontaneous reporting system   Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy 期刊论文 2019, 卷号: 27, 期号: 3, 页码: 244-256 作者:  Li, Kui;  Tian, Hongqi 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 Small-molecule inhibitors  PD-1  PD-L1 immune checkpoint  targeted therapy  tumour immunotherapy  clinical and preclinical research   Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies 期刊论文 2019, 卷号: 12, 期号: 1, 页码: 42 作者:  Wang, Dongxu;  Lin, Jianzhen;  Yang, Xu;  Long, Junyu;  Bai, Yi 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Gastrointestinal malignancies  PD-1/PD-L1 blockade  Immune checkpoint inhibitor  Combination immunotherapy  Clinical application  Rationale  Clinical trial   Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody 期刊论文 2019, 卷号: 10, 期号: 6, 页码: 1395-1401 作者:  Wang, Xi;  Zhang, Bo;  Chen, Xuelian;  Mo, Hongnan;  Wu, Dawei 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Esophageal squamous cell carcinoma  immune checkpoint inhibitor  lactate dehydrogenase  markers  programmed cell death-1   Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy 期刊论文 2019, 卷号: 9, 期号: 8, 页码: 2299-2314 作者:  Song, Huijuan;  Yang, Pengxiang;  Huang, Pingsheng;  Zhang, Chuangnian;  Kong, Deling 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Cancer immunotherapy  vaccine  immune checkpoint blockade  hydrogel  drug delivery